REBECA MENDEZ: Open Payments
NPI 1962098095 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 73 payments from 14 companies in 2025. Trend: 2023 $16 · 2024 $623 · 2025 $1,393
Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $381 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $268 |
| Vanda Pharmaceuticals Inc. | 12 | $256 |
| Axsome Therapeutics, Inc. | 4 | $110 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Lundbeck LLC | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Corium, LLC | 2 | $40 |
| Alkermes, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, Auvelity, COBENFY, Azstarys, ARISTADA.
Industry payments across FL — which companies pay providers there.
